A Novel Approach to the Treatment of IgA Nephropathy
This lunch talk at GlomCon Hawaii 2024 is sponsored by Calliditas Speakers: Dr. Anand Reddy, MRCP (UK), FACP, FASN Dr. Richard Lafayette, Professor of Medicine and Director, Stanford Glomerular Disease Center -------- Introducing GlomCon Hawaii 2024 GlomCon Hawaii 2024 launches an exciting new chapter in our learning experience: a hybrid event that combines a Satellite Symposium with core conference sessions, all hosted in Maui at the idyllic Grand Wailea, A Waldorf Astoria Resort! The mission of GlomCon is to provide medical education based on the best available evidence, free of commercial and ideological bias. That focus — and, since 2016, a successful track record of more than 250 live virtual seminars — revealed a natural next step: bringing the GlomCon community together for deeper learning, sharing, and networking. Our purpose-built GlomCon Hawaii 2024 conference agenda combines case presentations, pathology and treatment overviews, and lively panel discussions. This varied format helps us deliver clinical and scientific value to all attendees and ensures we continue advancing knowledge in our field. Satellite Symposium Full GlomCon Hawaii 2024 programming is available virtually and in person. A Satellite Symposium on August 6 will feature leading experts in clinical trials. Topics include: Clinical trial design Patient recruitment challenges Regulatory updates Post-market evaluation Clinical endpoints for glomerular diseases Core Conference GlomCon Hawaii 2024’s core conference continues Aug. 7–9. Areas of focus include: Aug. 7 — Renal pathologists will present in-depth, interactive lectures on the histopathology of lupus nephritis, small vessel vasculitis, podocytophathies, paraprotein-related kidney disease, and IgA nephropathy, Aug. 8–9 — A combination of lectures, case presentations, and case-based panel discussions will dissect clinicopathological correlations and evidence-based treatment approaches in all major glomerular diseases. This hybrid conference marks a much-anticipated expansion in GlomCon’s collaborative learning resources. Visit us 👇 www.glomcon.org www.pubs.glomcon.org

Atacicept; A Novel Inhibitor of BAFF and APRIL In Development for the Treatment of IgAN

Targeted Disease Modification in IgA Nephropathy

Antibody-Mediated Rejection of the Kidney Allograft - A Practical Update

Welcome Address by Dr. Ali Poyan Mehr | GlomCon Hawaii 2024

Updates to the KDIGO Guidelines for the treatment of IgA nephropathy, with Prof Jonathan Barratt

IgA Nephropathy Uncovered: Symptoms, Diagnosis & Latest Treatments

Kidney Disease: My Story of Kidney Failure

Goodbye Proteinuria! 3 Superfoods Seniors MUST Have and 5 You Should NEVER Touch

IgA Nephropathy: Developing a Non-Immunosuppressive Therapy

Are Eggs & Dairy Hard On The Kidneys?

Living with IgA Nephropathy: A Mother’s Journey

FSGS Treatment and Updates

IgA nephropathy and novel treatments

Current issues in ANCA associated vasculitis

Understanding Your Kidney Bloodwork And When To See A Nephrologist With Dr Pandeya

Updates in IgA Nephropathy - Part 1 with Dr. Brad Rovin

A beginners Guide to IgAN

New Glucose-Lowering Drugs and Kidney Protection in CKD

Positive Interim Results From Study of IgA Nephropathy Treatment

